SIMILAR PATTERNS OF AMINO ACIDS FOR 4ODR_A_FK5A201

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1b7g PROTEIN
(GLYCERALDEHYDE
3-PHOSPHATE
DEHYDROGENASE)

(Sulfolobus
solfataricus) 		PF01113
(DapB_N)
PF02800
(Gp_dh_C) 		5 LEU O 248
LEU O 237
ILE O 236
ILE O 223
ILE O 225
 None
 0.88A 4odrA-1b7gO:
undetectable
4odrB-1b7gO:
undetectable		 4odrA-1b7gO:
15.63
4odrB-1b7gO:
15.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fd9 PROTEIN (MACROPHAGE
INFECTIVITY
POTENTIATOR PROTEIN)

(Legionella
pneumophila) 		PF00254
(FKBP_C)
PF01346
(FKBP_N) 		6 TYR A 131
ASP A 142
ILE A 159
TYR A 185
ILE A 194
PHE A 202
 None
 0.65A 4odrA-1fd9A:
11.0
4odrB-1fd9A:
11.1		 4odrA-1fd9A:
19.15
4odrB-1fd9A:
19.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1fkk FK506 BINDING
PROTEIN

(Bos taurus) 		PF00254
(FKBP_C) 		7 TYR A  26
ASP A  37
ILE A  56
TYR A  82
ILE A  90
ILE A  91
PHE A  99
 None
 0.62A 4odrA-1fkkA:
13.9
4odrB-1fkkA:
14.0		 4odrA-1fkkA:
32.79
4odrB-1fkkA:
32.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1imv PIGMENT
EPITHELIUM-DERIVED
FACTOR

(Homo sapiens) 		PF00079
(Serpin) 		5 LEU A 370
ILE A 254
LEU A 246
ILE A 392
PRO A 395
 None
 0.87A 4odrA-1imvA:
undetectable
4odrB-1imvA:
undetectable		 4odrA-1imvA:
14.29
4odrB-1imvA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jvw MACROPHAGE
INFECTIVITY
POTENTIATOR

(Trypanosoma
cruzi) 		PF00254
(FKBP_C) 		6 TYR A  92
ASP A 103
ILE A 120
TYR A 146
ILE A 155
PHE A 163
 None
 0.76A 4odrA-1jvwA:
9.9
4odrB-1jvwA:
9.9		 4odrA-1jvwA:
26.88
4odrB-1jvwA:
26.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mjt NITRIC-OXIDE
SYNTHASE HOMOLOG

(Staphylococcus
aureus) 		PF02898
(NO_synthase) 		6 LEU A  28
ILE A  31
TYR A  41
ILE A 212
ILE A 215
PRO A 340
 None
 1.39A 4odrA-1mjtA:
undetectable
4odrB-1mjtA:
undetectable		 4odrA-1mjtA:
14.12
4odrB-1mjtA:
14.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1n1a FKBP52

(Homo sapiens) 		PF00254
(FKBP_C) 		6 TYR A  57
ASP A  68
ILE A  87
TYR A 113
ILE A 122
PHE A 130
 None
 0.61A 4odrA-1n1aA:
12.9
4odrB-1n1aA:
13.0		 4odrA-1n1aA:
25.17
4odrB-1n1aA:
25.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nog CONSERVED
HYPOTHETICAL PROTEIN
TA0546

(Thermoplasma
acidophilum) 		PF01923
(Cob_adeno_trans) 		5 LEU A 115
LEU A  35
LEU A 149
ILE A 152
ILE A  51
 None
 0.97A 4odrA-1nogA:
undetectable
4odrB-1nogA:
undetectable		 4odrA-1nogA:
21.11
4odrB-1nogA:
21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1pbk FKBP25

(Homo sapiens) 		PF00254
(FKBP_C) 		7 TYR A 135
ASP A 146
LEU A 162
ILE A 172
TYR A 198
ILE A 208
PHE A 216
 RAP  A 225 (-3.9A)
RAP  A 225 (-3.0A)
RAP  A 225 (-4.8A)
RAP  A 225 (-3.9A)
RAP  A 225 (-4.6A)
RAP  A 225 ( 4.9A)
None
 0.49A 4odrA-1pbkA:
13.2
4odrB-1pbkA:
13.2		 4odrA-1pbkA:
28.06
4odrB-1pbkA:
28.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q6h FKBP-TYPE
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKPA

(Escherichia
coli) 		PF00254
(FKBP_C)
PF01346
(FKBP_N) 		6 TYR A 146
ASP A 157
ILE A 174
TYR A 200
ILE A 208
PHE A 216
 None
 0.64A 4odrA-1q6hA:
11.1
4odrB-1q6hA:
11.0		 4odrA-1q6hA:
22.28
4odrB-1q6hA:
22.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q6h FKBP-TYPE
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKPA

(Escherichia
coli) 		PF00254
(FKBP_C)
PF01346
(FKBP_N) 		6 TYR A 146
LEU A 166
ILE A 174
TYR A 200
ILE A 208
PHE A 216
 None
 0.79A 4odrA-1q6hA:
11.1
4odrB-1q6hA:
11.0		 4odrA-1q6hA:
22.28
4odrB-1q6hA:
22.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q8i DNA POLYMERASE II

(Escherichia
coli) 		PF00136
(DNA_pol_B)
PF03104
(DNA_pol_B_exo1) 		5 LEU A 230
ASP A 229
LEU A 165
LEU A 205
ILE A 220
 None
 0.89A 4odrA-1q8iA:
undetectable
4odrB-1q8iA:
undetectable		 4odrA-1q8iA:
8.05
4odrB-1q8iA:
8.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1r9h FK506 BINDING
PROTEIN FAMILY

(Caenorhabditis
elegans) 		PF00254
(FKBP_C) 		6 TYR A  40
ASP A  51
ILE A  70
TYR A  96
ILE A 105
PHE A 113
 None
 0.73A 4odrA-1r9hA:
13.1
4odrB-1r9hA:
13.1		 4odrA-1r9hA:
23.78
4odrB-1r9hA:
23.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1riy HU DNA-BINDING
PROTEIN

(Thermotoga
maritima) 		PF00216
(Bac_DNA_binding) 		5 LEU A   6
LEU A  25
ILE A  28
LEU A  29
ILE A  44
 None
 0.98A 4odrA-1riyA:
undetectable
4odrB-1riyA:
undetectable		 4odrA-1riyA:
19.13
4odrB-1riyA:
19.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rp3 ANTI SIGMA FACTOR
FLGM
RNA POLYMERASE SIGMA
FACTOR SIGMA-28
(FLIA)

(Aquifex
aeolicus) 		PF04316
(FlgM)
PF04539
(Sigma70_r3)
PF04542
(Sigma70_r2)
PF04545
(Sigma70_r4) 		6 LEU B  46
LEU B   7
ILE B  11
LEU A  16
ILE A  48
ILE A  51
 None
 1.44A 4odrA-1rp3B:
undetectable
4odrB-1rp3B:
undetectable		 4odrA-1rp3B:
22.50
4odrB-1rp3B:
22.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u79 FKBP-TYPE
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
3

(Arabidopsis
thaliana) 		PF00254
(FKBP_C) 		7 TYR A  37
ASP A  48
LEU A  57
ILE A  67
TYR A  99
ILE A 113
PHE A 121
 None
 0.72A 4odrA-1u79A:
12.3
4odrB-1u79A:
12.2		 4odrA-1u79A:
24.11
4odrB-1u79A:
24.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1um8 ATP-DEPENDENT CLP
PROTEASE ATP-BINDING
SUBUNIT CLPX

(Helicobacter
pylori) 		PF07724
(AAA_2)
PF10431
(ClpB_D2-small) 		5 TYR A 111
LEU A 166
LEU A  85
ILE A 276
ILE A 145
 None
 0.90A 4odrA-1um8A:
undetectable
4odrB-1um8A:
undetectable		 4odrA-1um8A:
15.86
4odrB-1um8A:
15.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1yat FK506 BINDING
PROTEIN

(Saccharomyces
cerevisiae) 		PF00254
(FKBP_C) 		6 TYR A  26
ASP A  37
ILE A  56
TYR A  82
ILE A  91
PHE A  99
 FK5  A 108 ( 4.0A)
FK5  A 108 ( 3.3A)
FK5  A 108 ( 3.7A)
FK5  A 108 ( 4.7A)
None
None
 0.37A 4odrA-1yatA:
13.5
4odrB-1yatA:
13.5		 4odrA-1yatA:
30.09
4odrB-1yatA:
30.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zb7 NEUROTOXIN

(Clostridium
botulinum) 		PF01742
(Peptidase_M27) 		5 LEU A 228
LEU A 360
ILE A 112
LEU A 109
ILE A 193
 None
 1.00A 4odrA-1zb7A:
undetectable
4odrB-1zb7A:
undetectable		 4odrA-1zb7A:
13.41
4odrB-1zb7A:
13.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zvt TOPOISOMERASE IV
SUBUNIT A

(Escherichia
coli) 		PF03989
(DNA_gyraseA_C) 		5 LEU A 689
LEU A 698
LEU A 692
ILE A 672
ILE A 671
 None
 0.99A 4odrA-1zvtA:
undetectable
4odrB-1zvtA:
undetectable		 4odrA-1zvtA:
19.05
4odrB-1zvtA:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bm3 SCAFFOLDING DOCKERIN
BINDING PROTEIN A

(Ruminiclostridium
thermocellum) 		PF00963
(Cohesin) 		6 LEU A 149
LEU A  97
ILE A 117
LEU A  73
ILE A   9
PHE A  36
 None
 1.33A 4odrA-2bm3A:
undetectable
4odrB-2bm3A:
undetectable		 4odrA-2bm3A:
18.82
4odrB-2bm3A:
18.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2djt UNNAMED PROTEIN
PRODUCT

(Homo sapiens) 		PF00595
(PDZ) 		5 LEU A  28
LEU A  45
ILE A  94
ILE A  83
ILE A  66
 None
 0.83A 4odrA-2djtA:
undetectable
4odrB-2djtA:
undetectable		 4odrA-2djtA:
18.52
4odrB-2djtA:
18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A 376
LEU A 384
LEU A 284
LEU A 453
ILE A 312
 None
 0.94A 4odrA-2jiiA:
undetectable
4odrB-2jiiA:
undetectable		 4odrA-2jiiA:
14.41
4odrB-2jiiA:
14.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2oo3 PROTEIN INVOLVED IN
CATABOLISM OF
EXTERNAL DNA

(Legionella
pneumophila) 		PF04378
(RsmJ) 		6 TYR A 262
LEU A 259
ILE A  65
TYR A  82
ILE A  20
PRO A  76
 None
None
None
None
None
SO4  A 303 (-4.5A)
 1.31A 4odrA-2oo3A:
undetectable
4odrB-2oo3A:
undetectable		 4odrA-2oo3A:
15.85
4odrB-2oo3A:
15.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2oo3 PROTEIN INVOLVED IN
CATABOLISM OF
EXTERNAL DNA

(Legionella
pneumophila) 		PF04378
(RsmJ) 		6 TYR A 262
LEU A 259
TYR A  82
ILE A  20
PHE A 263
PRO A  76
 None
None
None
None
None
SO4  A 303 (-4.5A)
 1.28A 4odrA-2oo3A:
undetectable
4odrB-2oo3A:
undetectable		 4odrA-2oo3A:
15.85
4odrB-2oo3A:
15.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2pbc FK506-BINDING
PROTEIN 2

(Homo sapiens) 		PF00254
(FKBP_C) 		6 TYR A  56
ASP A  67
ILE A  86
TYR A 112
ILE A 121
PHE A 129
 PEG  A 201 (-4.4A)
None
PEG  A 201 (-3.8A)
None
None
None
 0.54A 4odrA-2pbcA:
14.5
4odrB-2pbcA:
14.3		 4odrA-2pbcA:
33.33
4odrB-2pbcA:
33.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qvw GLP_546_48378_50642

(Giardia
intestinalis) 		PF00636
(Ribonuclease_3)
PF02170
(PAZ) 		5 LEU A 620
LEU A 632
ILE A 633
ILE A 611
PRO A 697
 None
 0.95A 4odrA-2qvwA:
2.3
4odrB-2qvwA:
2.3		 4odrA-2qvwA:
10.20
4odrB-2qvwA:
10.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vn1 70 KDA
PEPTIDYLPROLYL
ISOMERASE

(Plasmodium
falciparum) 		PF00254
(FKBP_C) 		6 TYR A  44
ASP A  56
ILE A  75
TYR A 101
ILE A 110
PHE A 118
 FK5  A 501 (-4.1A)
FK5  A 501 (-3.4A)
FK5  A 501 (-4.3A)
FK5  A 501 (-4.7A)
None
FK5  A 501 (-4.8A)
 0.42A 4odrA-2vn1A:
13.1
4odrB-2vn1A:
13.3		 4odrA-2vn1A:
23.36
4odrB-2vn1A:
23.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vrt RIBONUCLEASE E

(Escherichia
coli) 		PF00575
(S1)
PF10150
(RNase_E_G) 		6 ASP A 303
LEU A 384
ILE A 343
LEU A 299
ILE A 291
ILE A 293
 None
 1.38A 4odrA-2vrtA:
undetectable
4odrB-2vrtA:
undetectable		 4odrA-2vrtA:
14.23
4odrB-2vrtA:
14.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wlc POLYSIALIC ACID
O-ACETYLTRANSFERASE

(Neisseria
meningitidis) 		PF00132
(Hexapep) 		6 LEU A  28
LEU A  70
LEU A  80
LEU A  74
ILE A  17
ILE A  15
 None
 1.40A 4odrA-2wlcA:
undetectable
4odrB-2wlcA:
undetectable		 4odrA-2wlcA:
20.69
4odrB-2wlcA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wtb FATTY ACID
MULTIFUNCTIONAL
PROTEIN (ATMFP2)

(Arabidopsis
thaliana) 		PF00378
(ECH_1)
PF00725
(3HCDH)
PF02737
(3HCDH_N) 		6 ASP A 253
LEU A 231
LEU A 164
ILE A 167
LEU A 168
ILE A 145
 None
 1.31A 4odrA-2wtbA:
undetectable
4odrB-2wtbA:
undetectable		 4odrA-2wtbA:
8.97
4odrB-2wtbA:
8.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2x3k ACSD

(Dickeya
chrysanthemi) 		PF04183
(IucA_IucC)
PF06276
(FhuF) 		5 ASP A 480
LEU A 321
LEU A 470
ILE A 476
LEU A 491
 None
 0.97A 4odrA-2x3kA:
undetectable
4odrB-2x3kA:
undetectable		 4odrA-2x3kA:
10.48
4odrB-2x3kA:
10.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y78 PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE

(Burkholderia
pseudomallei) 		PF00254
(FKBP_C) 		6 TYR A  33
ASP A  44
ILE A  63
TYR A  89
ILE A  98
PHE A 106
 None
 0.76A 4odrA-2y78A:
12.7
4odrB-2y78A:
12.7		 4odrA-2y78A:
25.00
4odrB-2y78A:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ywm GLUTAREDOXIN-LIKE
PROTEIN

(Aquifex
aeolicus) 		PF13192
(Thioredoxin_3) 		5 LEU A 109
ILE A  51
LEU A  11
ILE A  87
ILE A  25
 None
 0.99A 4odrA-2ywmA:
undetectable
4odrB-2ywmA:
undetectable		 4odrA-2ywmA:
19.65
4odrB-2ywmA:
19.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ceu THIAMINE PHOSPHATE
PYROPHOSPHORYLASE

(Bacteroides
thetaiotaomicron) 		PF02581
(TMP-TENI) 		5 LEU A  27
ASP A  28
ILE A  57
ILE A   4
PHE A  23
 None
 1.00A 4odrA-3ceuA:
undetectable
4odrB-3ceuA:
undetectable		 4odrA-3ceuA:
20.81
4odrB-3ceuA:
20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cz8 PUTATIVE
SPORULATION-SPECIFIC
GLYCOSYLASE YDHD

(Bacillus
subtilis) 		PF00704
(Glyco_hydro_18) 		6 LEU A 191
LEU A 233
ILE A 209
LEU A 226
ILE A 141
PHE A 225
 None
 1.39A 4odrA-3cz8A:
undetectable
4odrB-3cz8A:
undetectable		 4odrA-3cz8A:
16.46
4odrB-3cz8A:
16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cz8 PUTATIVE
SPORULATION-SPECIFIC
GLYCOSYLASE YDHD

(Bacillus
subtilis) 		PF00704
(Glyco_hydro_18) 		6 LEU A 233
ILE A 209
LEU A 226
ILE A 141
ILE A 135
PHE A 225
 None
 1.39A 4odrA-3cz8A:
undetectable
4odrB-3cz8A:
undetectable		 4odrA-3cz8A:
16.46
4odrB-3cz8A:
16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ebb PHOSPHOLIPASE
A2-ACTIVATING
PROTEIN

(Homo sapiens) 		PF08324
(PUL) 		5 LEU A 599
LEU A 552
ILE A 551
LEU A 555
PRO A 591
 None
 0.92A 4odrA-3ebbA:
undetectable
4odrB-3ebbA:
undetectable		 4odrA-3ebbA:
15.89
4odrB-3ebbA:
15.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fsn RETINAL PIGMENT
EPITHELIUM-SPECIFIC
65 KDA PROTEIN

(Bos taurus) 		PF03055
(RPE65) 		5 LEU A 383
ILE A 401
LEU A 395
TYR A 304
ILE A 300
 None
 0.98A 4odrA-3fsnA:
undetectable
4odrB-3fsnA:
undetectable		 4odrA-3fsnA:
12.84
4odrB-3fsnA:
12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3igs N-ACETYLMANNOSAMINE-
6-PHOSPHATE
2-EPIMERASE 2

(Salmonella
enterica) 		PF04131
(NanE) 		5 LEU A 118
ILE A 122
LEU A 119
ILE A  70
ILE A 101
 None
 0.99A 4odrA-3igsA:
undetectable
4odrB-3igsA:
undetectable		 4odrA-3igsA:
19.56
4odrB-3igsA:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iz3 STRUCTURAL PROTEIN
VP1

(Cypovirus 1) 		no annotation 5 LEU B 702
LEU B 767
ILE B 766
ILE B 482
PRO B 636
 None
 0.92A 4odrA-3iz3B:
undetectable
4odrB-3iz3B:
undetectable		 4odrA-3iz3B:
6.57
4odrB-3iz3B:
6.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l4k DNA TOPOISOMERASE 2

(Saccharomyces
cerevisiae) 		PF00521
(DNA_topoisoIV)
PF01751
(Toprim)
PF16898
(TOPRIM_C) 		5 LEU A1170
LEU A 847
ILE A 850
ILE A 794
ILE A 821
 None
 0.97A 4odrA-3l4kA:
undetectable
4odrB-3l4kA:
undetectable		 4odrA-3l4kA:
9.25
4odrB-3l4kA:
9.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lti DNA-DIRECTED RNA
POLYMERASE SUBUNIT
BETA

(Escherichia
coli) 		PF04561
(RNA_pol_Rpb2_2) 		6 ASP A 427
LEU A 223
LEU A 210
ILE A 209
LEU A 213
ILE A 176
 None
MLY  A 430 ( 4.4A)
None
None
MLY  A 422 ( 4.1A)
None
 1.38A 4odrA-3ltiA:
undetectable
4odrB-3ltiA:
undetectable		 4odrA-3ltiA:
16.04
4odrB-3ltiA:
16.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lxx GTPASE IMAP FAMILY
MEMBER 4

(Homo sapiens) 		PF04548
(AIG1) 		5 LEU A 205
LEU A  31
ILE A  33
LEU A  81
ILE A 152
 None
 1.01A 4odrA-3lxxA:
undetectable
4odrB-3lxxA:
undetectable		 4odrA-3lxxA:
15.48
4odrB-3lxxA:
15.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o5d PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP5

(Homo sapiens) 		PF00254
(FKBP_C) 		6 TYR A  57
ASP A  68
ILE A  87
TYR A 113
ILE A 122
PHE A 130
 None
 0.71A 4odrA-3o5dA:
11.3
4odrB-3o5dA:
11.4		 4odrA-3o5dA:
16.41
4odrB-3o5dA:
16.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o5e PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP5

(Homo sapiens) 		PF00254
(FKBP_C) 		6 TYR A  57
ASP A  68
ILE A  87
TYR A 113
ILE A 122
PHE A 130
 None
 0.66A 4odrA-3o5eA:
12.8
4odrB-3o5eA:
12.8		 4odrA-3o5eA:
22.93
4odrB-3o5eA:
22.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pa7 70 KDA
PEPTIDYLPROLYL
ISOMERASE, PUTATIVE

(Plasmodium
vivax) 		PF00254
(FKBP_C) 		6 TYR A  43
ASP A  55
ILE A  74
TYR A 100
ILE A 109
PHE A 117
 None
 0.80A 4odrA-3pa7A:
12.6
4odrB-3pa7A:
12.6		 4odrA-3pa7A:
23.85
4odrB-3pa7A:
23.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qhq SAG0897 FAMILY
CRISPR-ASSOCIATED
PROTEIN

(Streptococcus
agalactiae) 		PF09711
(Cas_Csn2) 		5 LEU A   9
LEU A 194
ILE A  23
LEU A  32
PHE A   6
 None
 0.96A 4odrA-3qhqA:
undetectable
4odrB-3qhqA:
undetectable		 4odrA-3qhqA:
19.92
4odrB-3qhqA:
19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s5c LINA

(uncultured
organism) 		no annotation 5 LEU B  64
LEU B 100
ILE B 109
ILE B  47
ILE B  44
 None
 0.99A 4odrA-3s5cB:
undetectable
4odrB-3s5cB:
undetectable		 4odrA-3s5cB:
18.99
4odrB-3s5cB:
18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t7i REGULATOR OF TY1
TRANSPOSITION
PROTEIN 107

(Saccharomyces
cerevisiae) 		PF16770
(RTT107_BRCT_5)
PF16771
(RTT107_BRCT_6) 		5 TYR A 835
LEU A 860
LEU A 927
ILE A 906
ILE A 913
 None
 1.01A 4odrA-3t7iA:
undetectable
4odrB-3t7iA:
undetectable		 4odrA-3t7iA:
14.45
4odrB-3t7iA:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vvj OVALBUMIN

(Dromaius
novaehollandiae) 		PF00079
(Serpin) 		5 LEU A 175
LEU A 306
ILE A 316
TYR A 118
ILE A 122
 None
 0.96A 4odrA-3vvjA:
undetectable
4odrB-3vvjA:
undetectable		 4odrA-3vvjA:
15.05
4odrB-3vvjA:
15.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zh9 DELTA

(Bacillus
subtilis) 		PF06144
(DNA_pol3_delta) 		5 LEU B 222
LEU B 334
LEU B 337
ILE B 251
ILE B 255
 None
 0.98A 4odrA-3zh9B:
undetectable
4odrB-3zh9B:
undetectable		 4odrA-3zh9B:
13.54
4odrB-3zh9B:
13.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zus BOTULINUM NEUROTOXIN
TYPE A,
SYNAPTOSOMAL-ASSOCIA
TED PROTEIN 23

(Clostridium
botulinum;
Homo sapiens) 		PF01742
(Peptidase_M27)
PF07952
(Toxin_trans) 		5 LEU A 103
LEU A 108
LEU A 225
ILE A 226
PHE A 354
 None
 0.99A 4odrA-3zusA:
undetectable
4odrB-3zusA:
undetectable		 4odrA-3zusA:
7.99
4odrB-3zusA:
7.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a20 UBIQUITIN-LIKE
PROTEIN MDY2

(Saccharomyces
cerevisiae) 		PF00240
(ubiquitin) 		5 LEU A  99
ASP A 128
LEU A 119
LEU A 105
ILE A 106
 None
SO4  A1152 (-3.4A)
None
None
None
 0.98A 4odrA-4a20A:
undetectable
4odrB-4a20A:
undetectable		 4odrA-4a20A:
17.76
4odrB-4a20A:
17.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a8j ELONGATOR COMPLEX
PROTEIN 5

(Saccharomyces
cerevisiae) 		PF10483
(Elong_Iki1) 		5 LEU B 204
LEU B  12
ILE B  15
LEU B  16
PHE B  42
 None
 0.97A 4odrA-4a8jB:
undetectable
4odrB-4a8jB:
undetectable		 4odrA-4a8jB:
16.42
4odrB-4a8jB:
16.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bf8 FPR4

(Saccharomyces
cerevisiae) 		PF00254
(FKBP_C) 		5 ASP A 324
ILE A 342
TYR A 368
ILE A 376
PHE A 384
 None
 0.91A 4odrA-4bf8A:
11.5
4odrB-4bf8A:
11.6		 4odrA-4bf8A:
23.31
4odrB-4bf8A:
23.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bf8 FPR4

(Saccharomyces
cerevisiae) 		PF00254
(FKBP_C) 		5 TYR A 313
ASP A 324
ILE A 342
TYR A 368
PHE A 384
 None
 0.94A 4odrA-4bf8A:
11.5
4odrB-4bf8A:
11.6		 4odrA-4bf8A:
23.31
4odrB-4bf8A:
23.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bj1 PROTEIN RIF2

(Saccharomyces
cerevisiae) 		no annotation 5 LEU A 266
LEU A 229
ILE A 224
LEU A 149
PHE A 212
 None
 0.97A 4odrA-4bj1A:
undetectable
4odrB-4bj1A:
undetectable		 4odrA-4bj1A:
14.55
4odrB-4bj1A:
14.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dz3 PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE

(Burkholderia
pseudomallei) 		PF00254
(FKBP_C) 		6 TYR A  33
ASP A  44
ILE A  63
TYR A  89
ILE A  98
PHE A 106
 FK5  A 201 ( 3.9A)
FK5  A 201 (-3.5A)
FK5  A 201 (-3.8A)
FK5  A 201 (-4.7A)
None
FK5  A 201 (-4.8A)
 0.41A 4odrA-4dz3A:
13.5
4odrB-4dz3A:
13.3		 4odrA-4dz3A:
25.71
4odrB-4dz3A:
25.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ejs ELONGATOR COMPLEX
PROTEIN 5

(Saccharomyces
cerevisiae) 		PF10483
(Elong_Iki1) 		5 LEU B 204
LEU B  12
ILE B  15
LEU B  16
PHE B  42
 None
 0.85A 4odrA-4ejsB:
undetectable
4odrB-4ejsB:
undetectable		 4odrA-4ejsB:
17.52
4odrB-4ejsB:
17.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4iqc PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP1B

(Homo sapiens) 		PF00254
(FKBP_C) 		6 TYR A  26
ASP A  37
ILE A  56
TYR A  82
ILE A  91
PHE A  99
 None
 0.81A 4odrA-4iqcA:
13.5
4odrB-4iqcA:
13.7		 4odrA-4iqcA:
32.00
4odrB-4iqcA:
32.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4je3 CENTRAL KINETOCHORE
SUBUNIT CHL4
CENTRAL KINETOCHORE
SUBUNIT IML3

(Saccharomyces
cerevisiae) 		PF05238
(CENP-N)
no annotation 		5 LEU B 402
LEU B 416
ILE B 422
LEU B 413
ILE A 192
 None
 1.00A 4odrA-4je3B:
undetectable
4odrB-4je3B:
undetectable		 4odrA-4je3B:
26.13
4odrB-4je3B:
26.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kkd MANNAN-BINDING
LECTIN SERINE
PROTEASE 1

(Homo sapiens) 		PF00084
(Sushi)
PF00089
(Trypsin) 		5 LEU A 574
LEU A 493
ILE A 492
LEU A 556
PRO A 434
 None
 0.89A 4odrA-4kkdA:
undetectable
4odrB-4kkdA:
undetectable		 4odrA-4kkdA:
11.78
4odrB-4kkdA:
11.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4law PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP4

(Homo sapiens) 		PF00254
(FKBP_C) 		5 TYR A  57
ASP A  68
ILE A  87
ILE A 122
PHE A 130
 None
None
DMS  A 304 (-3.8A)
None
DMS  A 304 (-4.3A)
 0.72A 4odrA-4lawA:
12.5
4odrB-4lawA:
12.6		 4odrA-4lawA:
17.95
4odrB-4lawA:
17.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4law PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP4

(Homo sapiens) 		PF00254
(FKBP_C) 		5 TYR A  57
ILE A  87
TYR A 113
ILE A 122
PHE A 130
 None
DMS  A 304 (-3.8A)
None
None
DMS  A 304 (-4.3A)
 0.53A 4odrA-4lawA:
12.5
4odrB-4lawA:
12.6		 4odrA-4lawA:
17.95
4odrB-4lawA:
17.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nnr PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP2

(Homo sapiens) 		PF00254
(FKBP_C) 		6 TYR A  56
ASP A  67
ILE A  86
TYR A 112
ILE A 121
PHE A 129
 FK5  A 201 (-4.1A)
FK5  A 201 (-3.4A)
FK5  A 201 (-3.8A)
FK5  A 201 (-4.5A)
None
FK5  A 201 (-4.9A)
 0.36A 4odrA-4nnrA:
15.1
4odrB-4nnrA:
14.9		 4odrA-4nnrA:
28.47
4odrB-4nnrA:
28.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4odm PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
SLYD

(Thermus
thermophilus) 		PF00254
(FKBP_C) 		9 TYR A  13
LEU A  15
ASP A  23
LEU A  27
LEU A  36
ILE A  37
LEU A  40
TYR A  63
PHE A 128
 None
 0.53A 4odrA-4odmA:
18.6
4odrB-4odmA:
18.6		 4odrA-4odmA:
61.44
4odrB-4odmA:
61.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4opm LIPASE

(Acinetobacter
baumannii) 		PF12697
(Abhydrolase_6) 		5 ASP A 269
LEU A 166
ILE A 263
LEU A 280
ILE A 292
 None
 0.99A 4odrA-4opmA:
undetectable
4odrB-4opmA:
undetectable		 4odrA-4opmA:
15.43
4odrB-4opmA:
15.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p81 ANCESTRAL PYRR
PROTEIN (ORANGE)

(synthetic
construct) 		PF00156
(Pribosyltran) 		5 LEU A 132
LEU A 121
LEU A  68
ILE A  40
ILE A 145
 None
 0.99A 4odrA-4p81A:
undetectable
4odrB-4p81A:
undetectable		 4odrA-4p81A:
19.25
4odrB-4p81A:
19.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pju COHESIN SUBUNIT SA-2

(Homo sapiens) 		PF08514
(STAG) 		5 LEU A 204
LEU A 182
ILE A 179
ILE A 288
PHE A 121
 None
 0.98A 4odrA-4pjuA:
undetectable
4odrB-4pjuA:
undetectable		 4odrA-4pjuA:
7.97
4odrB-4pjuA:
7.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4r0x PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP5

(Homo sapiens) 		PF00254
(FKBP_C) 		6 TYR A  57
ASP A  68
ILE A  87
TYR A 113
ILE A 122
PHE A 130
 None
 0.73A 4odrA-4r0xA:
13.2
4odrB-4r0xA:
13.1		 4odrA-4r0xA:
23.36
4odrB-4r0xA:
23.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4r10 PROTEIN HUMPBACK-2

(Caenorhabditis
elegans) 		PF00514
(Arm) 		6 LEU A 535
LEU A 563
ILE A 559
LEU A 562
ILE A 479
ILE A 499
 None
 1.25A 4odrA-4r10A:
undetectable
4odrB-4r10A:
undetectable		 4odrA-4r10A:
10.37
4odrB-4r10A:
10.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4s3o E3 UBIQUITIN-PROTEIN
LIGASE RING2
POLYCOMB GROUP RING
FINGER PROTEIN 5

(Homo sapiens) 		PF13923
(zf-C3HC4_2) 		5 LEU C  82
LEU B  45
LEU B  49
PHE B 106
PRO C  28
 None
 1.01A 4odrA-4s3oC:
undetectable
4odrB-4s3oC:
undetectable		 4odrA-4s3oC:
23.26
4odrB-4s3oC:
23.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4udn PERIPLASMIC SOLUTE
BINDING PROTEIN

(Candidatus
Liberibacter
asiaticus) 		PF01297
(ZnuA) 		5 LEU A 263
LEU A 244
LEU A 175
LEU A 178
ILE A  13
 None
 1.01A 4odrA-4udnA:
undetectable
4odrB-4udnA:
undetectable		 4odrA-4udnA:
19.07
4odrB-4udnA:
19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zo3 ACYLHOMOSERINE
LACTONASE

(Chryseobacterium
sp. StRB126) 		PF00753
(Lactamase_B) 		5 LEU A 124
LEU A 108
ILE A 141
ILE A 208
ILE A 212
 None
 1.00A 4odrA-4zo3A:
undetectable
4odrB-4zo3A:
undetectable		 4odrA-4zo3A:
17.35
4odrB-4zo3A:
17.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5b8i PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
SERINE/THREONINE-PRO
TEIN PHOSPHATASE

(Coccidioides
immitis) 		PF00149
(Metallophos)
PF00254
(FKBP_C) 		7 TYR C  36
ASP C  56
ILE C  74
TYR C 100
ILE C 109
PHE C 117
PRO A 362
 FK5  C 201 (-4.1A)
FK5  C 201 ( 3.8A)
FK5  C 201 (-3.8A)
FK5  C 201 (-4.5A)
None
FK5  C 201 (-4.7A)
EDO  C 202 ( 4.0A)
 0.55A 4odrA-5b8iC:
13.1
4odrB-5b8iC:
13.2		 4odrA-5b8iC:
29.17
4odrB-5b8iC:
29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5civ SIBLING BACTERIOCIN

(Paenibacillus
dendritiformis) 		PF08020
(DUF1706) 		5 TYR A  31
LEU A  34
ASP A  35
LEU A  68
ILE A  60
 None
 0.98A 4odrA-5civA:
undetectable
4odrB-5civA:
undetectable		 4odrA-5civA:
17.39
4odrB-5civA:
17.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5d3m ENERGY-COUPLING
FACTOR TRANSPORTER
ATP-BINDING PROTEIN
ECFA1

(Lactobacillus
delbrueckii) 		PF00005
(ABC_tran) 		5 LEU A  38
LEU A  23
LEU A  52
ILE A  53
ILE A  30
 None
 0.91A 4odrA-5d3mA:
undetectable
4odrB-5d3mA:
undetectable		 4odrA-5d3mA:
15.77
4odrB-5d3mA:
15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eft P9-1

(Southern rice
black-streaked
dwarf virus) 		PF06043
(Reo_P9) 		5 LEU B 253
LEU B 204
LEU B 207
ILE B  52
PHE B 261
 None
 1.01A 4odrA-5eftB:
undetectable
4odrB-5eftB:
undetectable		 4odrA-5eftB:
16.47
4odrB-5eftB:
16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gj8 ACYL-COA
DEHYDROGENASE TYPE 2
DOMAIN PROTEIN

(Alicyclobacillus
acidocaldarius) 		PF02770
(Acyl-CoA_dh_M)
PF02771
(Acyl-CoA_dh_N)
PF08028
(Acyl-CoA_dh_2) 		6 LEU A 189
LEU A  98
ILE A  97
LEU A 101
ILE A 173
PHE A 107
 None
 1.49A 4odrA-5gj8A:
undetectable
4odrB-5gj8A:
undetectable		 4odrA-5gj8A:
13.92
4odrB-5gj8A:
13.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hb4 NUP192,NUCLEOPORIN
NUP192

(Chaetomium
thermophilum) 		PF11894
(Nup192) 		5 LEU B1066
LEU B1071
LEU B1101
ILE B1100
ILE B1021
 None
 0.92A 4odrA-5hb4B:
undetectable
4odrB-5hb4B:
undetectable		 4odrA-5hb4B:
5.31
4odrB-5hb4B:
5.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hiw CYTOCHROME P450
CYP260B1

(Sorangium
cellulosum) 		PF00067
(p450) 		5 LEU A 237
LEU A 244
LEU A 356
LEU A 355
PHE A 127
 None
 0.93A 4odrA-5hiwA:
undetectable
4odrB-5hiwA:
undetectable		 4odrA-5hiwA:
15.33
4odrB-5hiwA:
15.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i6e ACETYL-COA
CARBOXYLASE

(Saccharomyces
cerevisiae) 		PF08326
(ACC_central) 		5 LEU A1086
LEU A1075
ILE A1076
LEU A1072
ILE A1115
 None
 0.96A 4odrA-5i6eA:
undetectable
4odrB-5i6eA:
undetectable		 4odrA-5i6eA:
9.62
4odrB-5i6eA:
9.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i7p PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP1A,FKBP-TYPE
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
SLYD,PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP1A

(Escherichia
coli;
Homo sapiens) 		PF00254
(FKBP_C) 		5 TYR A  26
ASP A  37
ILE A  56
TYR A  82
PHE A 146
 None
 0.54A 4odrA-5i7pA:
12.0
4odrB-5i7pA:
12.2		 4odrA-5i7pA:
23.67
4odrB-5i7pA:
23.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i7q PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP1A,FKBP-TYPE 16
KDA PEPTIDYL-PROLYL
CIS-TRANS
ISOMERASE,PEPTIDYL-P
ROLYL CIS-TRANS
ISOMERASE FKBP1A

(Escherichia
coli;
Homo sapiens) 		PF00254
(FKBP_C) 		5 TYR A  26
ASP A  37
ILE A  56
TYR A  82
PHE A 147
 None
 0.59A 4odrA-5i7qA:
12.1
4odrB-5i7qA:
12.3		 4odrA-5i7qA:
26.70
4odrB-5i7qA:
26.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i98 FK506-BINDING
PROTEIN 1

(Candida
albicans) 		PF00254
(FKBP_C) 		7 TYR A  30
ASP A  41
ILE A  60
TYR A  97
ILE A 105
ILE A 106
PHE A 114
 None
 0.78A 4odrA-5i98A:
12.8
4odrB-5i98A:
12.8		 4odrA-5i98A:
26.43
4odrB-5i98A:
26.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j6e FK506-BINDING
PROTEIN 1A

(Aspergillus
fumigatus) 		PF00254
(FKBP_C) 		6 TYR A  27
ASP A  38
ILE A  57
TYR A  83
ILE A  92
PHE A 100
 None
 0.57A 4odrA-5j6eA:
13.4
4odrB-5j6eA:
13.4		 4odrA-5j6eA:
28.57
4odrB-5j6eA:
28.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kf7 BIFUNCTIONAL PROTEIN
PUTA

(Sinorhizobium
meliloti) 		PF00171
(Aldedh)
PF01619
(Pro_dh)
PF14850
(Pro_dh-DNA_bdg) 		6 LEU A 879
LEU A 551
LEU A 654
ILE A 658
LEU A 566
PHE A  21
 None
 1.47A 4odrA-5kf7A:
undetectable
4odrB-5kf7A:
undetectable		 4odrA-5kf7A:
6.32
4odrB-5kf7A:
6.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lxr RNA-BINDING PROTEIN
7
ZINC FINGER CCHC
DOMAIN-CONTAINING
PROTEIN 8

(Homo sapiens) 		PF00076
(RRM_1)
PF04046
(PSP) 		5 LEU B 295
ILE A  80
LEU A  70
ILE A  41
PHE A  30
 None
 0.99A 4odrA-5lxrB:
undetectable
4odrB-5lxrB:
undetectable		 4odrA-5lxrB:
14.43
4odrB-5lxrB:
14.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5m3c DIGUANYLATE CYCLASE

(Pseudomonas
aeruginosa) 		no annotation 5 LEU A1105
LEU A1089
ILE A1086
LEU A1085
PRO A1152
 None
 0.95A 4odrA-5m3cA:
undetectable
4odrB-5m3cA:
undetectable		 4odrA-5m3cA:
20.75
4odrB-5m3cA:
20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ojl IMINE REDUCTASE

(Aspergillus
terreus) 		no annotation 6 LEU A 158
LEU A  66
ILE A  68
LEU A  10
ILE A 123
PHE A  26
 None
None
None
None
TXP  A 302 (-4.3A)
None
 1.50A 4odrA-5ojlA:
undetectable
4odrB-5ojlA:
undetectable		 4odrA-5ojlA:
19.23
4odrB-5ojlA:
19.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tr0 SEED LINOLEATE
13S-LIPOXYGENASE-1

(Glycine max) 		no annotation 5 LEU A 299
LEU A 745
ILE A 746
LEU A 742
ILE A 265
 None
 0.94A 4odrA-5tr0A:
undetectable
4odrB-5tr0A:
undetectable		 4odrA-5tr0A:
9.47
4odrB-5tr0A:
9.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u8s CELL DIVISION
CONTROL PROTEIN 45

(Saccharomyces
cerevisiae) 		PF02724
(CDC45) 		5 LEU E  45
LEU E  16
ILE E  15
TYR E 121
PHE E  49
 None
 0.96A 4odrA-5u8sE:
undetectable
4odrB-5u8sE:
undetectable		 4odrA-5u8sE:
11.22
4odrB-5u8sE:
11.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uj7 ORIGIN RECOGNITION
COMPLEX SUBUNIT 5

(Homo sapiens) 		PF13191
(AAA_16)
PF14630
(ORC5_C) 		5 LEU E 144
LEU E 130
LEU E  72
ILE E  76
LEU E  73
 None
 1.00A 4odrA-5uj7E:
undetectable
4odrB-5uj7E:
undetectable		 4odrA-5uj7E:
16.37
4odrB-5uj7E:
16.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ujm ORIGIN RECOGNITION
COMPLEX SUBUNIT 5

(Homo sapiens) 		PF13191
(AAA_16)
PF14630
(ORC5_C) 		5 LEU E 144
LEU E 130
LEU E  72
ILE E  76
LEU E  73
 None
 1.00A 4odrA-5ujmE:
undetectable
4odrB-5ujmE:
undetectable		 4odrA-5ujmE:
13.97
4odrB-5ujmE:
13.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uq6 TARTRATE-RESISTANT
ACID PHOSPHATASE
TYPE 5

(Sus scrofa) 		PF00149
(Metallophos) 		6 LEU A 120
ILE A 133
ILE A 124
ILE A 278
PHE A  46
PRO A 125
 None
 1.39A 4odrA-5uq6A:
undetectable
4odrB-5uq6A:
undetectable		 4odrA-5uq6A:
15.29
4odrB-5uq6A:
15.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5v8t UBIQUITIN-LIKE
PROTEIN
SMT3,PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE

(Burkholderia
pseudomallei;
Saccharomyces
cerevisiae) 		no annotation 6 TYR A  33
ASP A  44
ILE A  63
TYR A  89
ILE A  98
PHE A 106
 8ZV  A 201 (-3.8A)
8ZV  A 201 (-3.9A)
8ZV  A 201 (-4.0A)
8ZV  A 201 (-4.6A)
8ZV  A 201 ( 4.8A)
8ZV  A 201 (-4.6A)
 0.39A 4odrA-5v8tA:
13.2
4odrB-5v8tA:
13.1		 4odrA-5v8tA:
18.35
4odrB-5v8tA:
18.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5va3 POTASSIUM
VOLTAGE-GATED
CHANNEL SUBFAMILY H
MEMBER 2

(Homo sapiens) 		PF00027
(cNMP_binding)
PF00520
(Ion_trans)
PF13426
(PAS_9) 		5 LEU A 779
LEU A 754
LEU A 842
ILE A 804
ILE A 858
 None
 0.98A 4odrA-5va3A:
undetectable
4odrB-5va3A:
undetectable		 4odrA-5va3A:
8.22
4odrB-5va3A:
8.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vjc PROTEIN MINI
SPINDLES

(Drosophila
melanogaster) 		no annotation 5 LEU A1262
LEU A1229
ILE A1232
LEU A1233
ILE A1211
 None
 0.99A 4odrA-5vjcA:
undetectable
4odrB-5vjcA:
undetectable		 4odrA-5vjcA:
17.74
4odrB-5vjcA:
17.74